The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1660
October 3, 2022
View Complete Issue         Table of Contents 2019 
Issue 1660
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Influenza Vaccine for 2022-2023
October 3, 2022 (Issue: 1660)
Annual vaccination in the US against influenza A and B viruses is recommended for everyone ≥6 months old without a contraindication. Influenza vaccines that are available in the US for the 2022-2023 season are listed in Table 2.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1660
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.